GABA receptor agonists in intention myoclonus

Measurement of the 235U fission cross section relative to the standard 10B(n, α) reaction at the CERN n_TOF facility: Results for En< 2 eV.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2025

Neutron capture measurements for s-process nucleosynthesis: A review about CERN n_TOF developments and contributions.

The European physical journal. A, Hadrons and nuclei·2025

Shedding Light on the Origin of ^{204}Pb, the Heaviest s-Process-Only Isotope in the Solar System.

Physical review letters·2024

Measurement of the ^{140}Ce(n,γ) Cross Section at n_TOF and Its Astrophysical Implications for the Chemical Evolution of the Universe.

Physical review letters·2024

<math></math> Ge( <math></math> ) cross section below 70 keV measured at n_TOF CERN.

The European physical journal. A, Hadrons and nuclei·2022

Neutron Capture on the s-Process Branching Point ^{171}Tm via Time-of-Flight and Activation.

Physical review letters·2020

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Revealing Griffithsin recognition of diverse virus-associated N-glycans using atomistic simulations: glycan compositions and branching patterns as key molecular determinants.

Physical chemistry chemical physics : PCCP·2026

Metabolite glues as a means of purine sensing and chemotherapeutic response.

Nature·2026

Induced ubiquitination of the partially disordered estrogen receptor alpha via a 14-3-3 directed molecular glue-PROTAC.

Nature communications·2026

Multifunctional polysaccharides for skin health: A review in antioxidant, anti-inflammatory, and regenerative mechanisms.

International journal of biological macromolecules·2026

Recent advances in the formulation and delivery applications of chitosan/Fucoidan nanoparticles.

International journal of biological macromolecules·2026

Impact of antigen and carrier substitution on the molecular weight and immunogenicity of the Pfs230D1-CRM197 malaria transmission-blocking vaccine.

Vaccine·2026

Related Experiment Videos

GABA receptor agonists in intention myoclonus

Related Concept Videos

Measurement of the <sup>235</sup>U fission cross section relative to the standard <sup>10</sup>B(n, α) reaction at the CERN n_TOF facility: Results for E<sub>n</sub>< 2 eV.

Neutron capture measurements for s-process nucleosynthesis: A review about CERN n_TOF developments and contributions.

Shedding Light on the Origin of ^{204}Pb, the Heaviest s-Process-Only Isotope in the Solar System.

Measurement of the ^{140}Ce(n,γ) Cross Section at n_TOF and Its Astrophysical Implications for the Chemical Evolution of the Universe.

<math></math> Ge( <math></math> ) cross section below 70 keV measured at n_TOF CERN.

Neutron Capture on the s-Process Branching Point ^{171}Tm via Time-of-Flight and Activation.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Revealing Griffithsin recognition of diverse virus-associated <i>N</i>-glycans using atomistic simulations: glycan compositions and branching patterns as key molecular determinants.

Metabolite glues as a means of purine sensing and chemotherapeutic response.

Induced ubiquitination of the partially disordered estrogen receptor alpha via a 14-3-3 directed molecular glue-PROTAC.

Multifunctional polysaccharides for skin health: A review in antioxidant, anti-inflammatory, and regenerative mechanisms.

Recent advances in the formulation and delivery applications of chitosan/Fucoidan nanoparticles.

Impact of antigen and carrier substitution on the molecular weight and immunogenicity of the Pfs230D1-CRM197 malaria transmission-blocking vaccine.

Related Experiment Videos

GABA receptor agonists in intention myoclonus

Related Concept Videos

Related Articles